Functioning Capital For Small Business Owners Needing Cash! + More Information: Report: BNP to be struck by $10bn great + MORE 05/31/2014

Executives at drug company Actavis knew they had to move fast to avoid a plunge in sales of their top-selling drug, Namenda, a treatment for Alzheimer’s disease that would lose patent protection in July.Read full article >>
Regulators take a growing interest in drug-makers’ moves to protectRead more...